This effect is largely attributed to the activation of hypoxia-inducible factor-1b (HIF-1b) in tumor cells, which increases the expression of glucose transporters and glycolytic enzymes, resulting in an upregulation of glycolysis [4, 6, 7, 46]. The gene discussed is ARNT; the disease is neoplasm.